tiprankstipranks
Trending News
More News >
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ:MIRM
US Market

Mirum Pharmaceuticals (MIRM) Income Statement

Compare
745 Followers

Mirum Pharmaceuticals Income Statement

Last quarter (Q4 2025), Mirum Pharmaceuticals's total revenue was $148.93M, an increase of 49.81% from the same quarter last year. In Q4, Mirum Pharmaceuticals's net income was $-5.73M. See Mirum Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 521.31M$ 336.89M$ 186.37M$ 77.06M$ 19.14M
Gross Profit
$ 420.73M$ 255.25M$ 139.34M$ 64.69M$ 17.23M
Operating Expenses
$ 443.21M$ 342.85M$ 248.49M$ 195.91M$ 190.65M
Depreciation and Amortization
$ 24.24M$ 23.63M$ 10.83M$ 3.24M$ 975.00K
EBITDA
$ 17.21M$ -48.97M$ -136.49M$ -122.85M$ -65.39M
Operating Income
$ -22.14M$ -87.61M$ -109.15M$ -131.22M$ -173.41M
Other Income/Expenses
$ 709.00K$ 694.00K$ -53.27M$ -10.85M$ 89.46M
Pretax Income
$ -21.43M$ -86.91M$ -162.42M$ -142.07M$ -83.95M
Net Income
$ -23.36M$ -87.94M$ -163.41M$ -135.66M$ -83.99M
Per Share Metrics
Basic EPS
$ -0.47$ -1.85$ -4.00$ -4.01$ -2.77
Diluted EPS
$ -0.47$ -1.85$ -4.00$ -4.02$ -2.77
Weighted Average Shares Outstanding
50.20M 47.52M 40.89M 33.84M 30.32M
Weighted Average Shares Outstanding (Diluted)
50.20M 47.52M 40.89M 33.98M 30.32M
Currency in USD

Mirum Pharmaceuticals Earnings and Revenue History